Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
or another serious condition your doctor has linked to your use of the drug
This double-blind, placebo-controlled trial randomized (1:1) adults with body mass index 30 or 27 kg/m 2 and at least one obesity-related complication (excluding diabetes), who achieved 5.0% weight reduction after a 12-week intensive lifestyle intervention, to tirzepatide maximum tolerated dose (10 or 15 mg) or placebo once weekly for 72 weeks ( n = 579)
Information on the use of weight-promoting medications during the time of semaglutide treatment was also collected
What Are the Symptoms of Major Gastrointestinal Bleeding
US$ 23.41
US$ 25.64
US$ 25.56
US$ 20.90
US$ 27.13
